PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Reginster, Jean-Yves
TI  - The SEKOIA Trial: A Structural and Symptomatic Efficacy
DP  - 2012  01
TA  - MD Conference Express
PG  - 20--20
VI  - 12
IP  - 19
4099  - http://mdc.sagepub.com/content/12/19/20.short
4100  - http://mdc.sagepub.com/content/12/19/20.full
AB  - Strontium ranelate, an antiosteoporotic drug developed for the treatment of postmenopausal osteoporosis, delayed radiographic progression of knee osteoarthritis and improved symptoms. This reports on The Efficacy and Safety of Two Doses of Strontium Ranelate Versus Placebo, Administered Orally for Three Years in the Treatment of Knee Osteoarthritis [SEKOIA] trial [Reginster JY et al. Ann Rheum Dis 2012].